Entry |
|
Name |
Ethybenztropine (USAN); Etybenzatropine (INN); Panolid (TN) |
Formula |
C22H27NO
|
Exact mass |
321.2093
|
Mol weight |
321.45
|
Structure |
|
Simcomp |
|
Class |
Neuropsychiatric agent
DG01491 Muscarinic cholinergic receptor antagonist
DG01745 Anticholinergic antiparkinson agent
|
Remark |
|
Efficacy |
Antiparkinsonian, Muscarinic acetylcholine receptor antagonist |
Comment |
Atropine [CPD: C01479] derivative
|
Target |
|
Pathway |
hsa04080 | Neuroactive ligand-receptor interaction |
|
Interaction |
|
Structure map |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N04 ANTI-PARKINSON DRUGS
N04A ANTICHOLINERGIC AGENTS
N04AC Ethers of tropine or tropine derivatives
N04AC30 Etybenzatropine
D04087 Ethybenztropine (USAN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01491 Muscarinic cholinergic receptor antagonist
DG01745 Anticholinergic antiparkinson agent
D04087 Ethybenztropine
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Acetylcholine (muscarinic)
CHRM
D04087 Ethybenztropine (USAN)
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 24
1 C1x C 11.5738 -12.2308
2 C1x C 11.9019 -11.0591
3 C1y C 12.7455 -11.9496
4 C1y C 13.0736 -10.7779
5 N1y N 11.8082 -9.4656
6 C1x C 14.6202 -11.9496
7 C1x C 14.3390 -10.7779
8 C1y C 15.6513 -12.5120
9 O2a O 16.7293 -13.4025
10 C1c C 17.9479 -13.4025
11 C8y C 18.5572 -12.3245
12 C8y C 18.5572 -14.5273
13 C1b C 11.0591 -8.2814
14 C1a C 9.6591 -8.2814
15 C8x C 19.9500 -12.3117
16 C8x C 20.6388 -11.0929
17 C8x C 19.9277 -9.8870
18 C8x C 18.5350 -9.8997
19 C8x C 17.8461 -11.1185
20 C8x C 17.8078 -15.7471
21 C8x C 18.4744 -16.9782
22 C8x C 19.8739 -17.0164
23 C8x C 20.6233 -15.7967
24 C8x C 19.9567 -14.5656
BOND 27
1 1 2 1
2 1 3 1
3 2 4 1
4 3 5 1
5 3 6 1
6 4 7 1
7 6 8 1
8 8 9 1
9 9 10 1
10 10 11 1
11 10 12 1
12 4 5 1
13 7 8 1
14 5 13 1
15 13 14 1
16 11 15 2
17 15 16 1
18 16 17 2
19 17 18 1
20 18 19 2
21 11 19 1
22 12 20 2
23 20 21 1
24 21 22 2
25 22 23 1
26 23 24 2
27 12 24 1
|